<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reproducible animal models of <z:hpo ids='HP_0001297'>stroke</z:hpo> are indispensable for investigation of pathogenesis and treatment of ischemic brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>Defined location and size of infarction as well as consistent production of neurological deficits make it possible to evaluate therapeutic potential of neuroprotective agents as well as to assess the impact of gene deletion [Nat </plain></SENT>
<SENT sid="2" pm="."><plain>Med </plain></SENT>
<SENT sid="3" pm="."><plain>3 (1997) 1089; Science 265 (1994) 1883; Nat </plain></SENT>
<SENT sid="4" pm="."><plain>Med </plain></SENT>
<SENT sid="5" pm="."><plain>4 (1998) 228] or overexpression [J </plain></SENT>
<SENT sid="6" pm="."><plain>Neurochem </plain></SENT>
<SENT sid="7" pm="."><plain>72 (1999) 1187; J </plain></SENT>
<SENT sid="8" pm="."><plain>Neurosci </plain></SENT>
<SENT sid="9" pm="."><plain>17 (1997) 7655] on neuroprotection in genetically altered mice </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0002140'>Ischemic stroke</z:hpo> in mice can be reliably replicated by means of an open craniectomy exposure followed by permanent occlusion of the trunk and branches of the middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) </plain></SENT>
<SENT sid="11" pm="."><plain>Open craniectomy model is known to be statistically robust, yielding a coefficient of variation of &lt;10%, and requiring minimal number of animals to validate the concept of statistical power </plain></SENT>
<SENT sid="12" pm="."><plain>In the past, this model as well as some of its variants had been used in pivotal scientific studies to demonstrate impact of therapeutic genes on the course of ischemic neuronal injury [Neuron 13 (1994) 1017], as well as identification of 'culprit genes' responsible for progression of ischemic injury [J </plain></SENT>
<SENT sid="13" pm="."><plain>Cerebr </plain></SENT>
<SENT sid="14" pm="."><plain>Blood Flow Metab </plain></SENT>
<SENT sid="15" pm="."><plain>14 (1994) 887; Science 265 (1994) 1883; J </plain></SENT>
<SENT sid="16" pm="."><plain>Neurosci </plain></SENT>
<SENT sid="17" pm="."><plain>17 (1997) 7655] through continuous recruitment of marginally ischemic penumbra into ischemic core [Trends Neurosci </plain></SENT>
<SENT sid="18" pm="."><plain>22 (1999) 391] </plain></SENT>
<SENT sid="19" pm="."><plain>This protocol describes mapping of the ischemic penumbra using <z:chebi fb="1" ids="16474">NADPH</z:chebi> diaphorase staining as well as assessment of penumbral endogenous <z:chebi fb="11" ids="22586">antioxidant</z:chebi> reserves by detection of cellular <z:chebi fb="0" ids="17033">biliverdin</z:chebi> reductase <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein levels using immunocytochemistry and in situ hybridization histological techniques </plain></SENT>
</text></document>